nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2A6—Tamoxifen—pancreatic cancer	0.182	0.289	CbGbCtD
Arformoterol—CYP2A6—Fluorouracil—pancreatic cancer	0.134	0.213	CbGbCtD
Arformoterol—CYP2C19—Tamoxifen—pancreatic cancer	0.0754	0.119	CbGbCtD
Arformoterol—CYP2C9—Tamoxifen—pancreatic cancer	0.0626	0.0993	CbGbCtD
Arformoterol—CYP2D6—Tamoxifen—pancreatic cancer	0.0573	0.0908	CbGbCtD
Arformoterol—CYP2D6—Erlotinib—pancreatic cancer	0.0487	0.0772	CbGbCtD
Arformoterol—CYP2C9—Fluorouracil—pancreatic cancer	0.0462	0.0732	CbGbCtD
Arformoterol—CYP2D6—Doxorubicin—pancreatic cancer	0.024	0.0381	CbGbCtD
Arformoterol—Pruritus—Sunitinib—pancreatic cancer	0.000341	0.000988	CcSEcCtD
Arformoterol—Pain—Irinotecan—pancreatic cancer	0.000339	0.000984	CcSEcCtD
Arformoterol—Constipation—Irinotecan—pancreatic cancer	0.000339	0.000984	CcSEcCtD
Arformoterol—Dyspnoea—Fluorouracil—pancreatic cancer	0.000339	0.000982	CcSEcCtD
Arformoterol—Mental disorder—Docetaxel—pancreatic cancer	0.000338	0.000981	CcSEcCtD
Arformoterol—Somnolence—Fluorouracil—pancreatic cancer	0.000338	0.000979	CcSEcCtD
Arformoterol—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000337	0.000976	CcSEcCtD
Arformoterol—Malnutrition—Docetaxel—pancreatic cancer	0.000336	0.000974	CcSEcCtD
Arformoterol—Dyspepsia—Fluorouracil—pancreatic cancer	0.000335	0.00097	CcSEcCtD
Arformoterol—Nausea—Tamoxifen—pancreatic cancer	0.000334	0.000969	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000334	0.000967	CcSEcCtD
Arformoterol—Fatigue—Gemcitabine—pancreatic cancer	0.000333	0.000966	CcSEcCtD
Arformoterol—Gastritis—Epirubicin—pancreatic cancer	0.000333	0.000966	CcSEcCtD
Arformoterol—Pain—Gemcitabine—pancreatic cancer	0.000331	0.000958	CcSEcCtD
Arformoterol—Constipation—Gemcitabine—pancreatic cancer	0.000331	0.000958	CcSEcCtD
Arformoterol—Nausea—Erlotinib—pancreatic cancer	0.000331	0.000958	CcSEcCtD
Arformoterol—Diarrhoea—Sunitinib—pancreatic cancer	0.00033	0.000956	CcSEcCtD
Arformoterol—Dysgeusia—Docetaxel—pancreatic cancer	0.000329	0.000954	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000328	0.000951	CcSEcCtD
Arformoterol—Feeling abnormal—Irinotecan—pancreatic cancer	0.000327	0.000948	CcSEcCtD
Arformoterol—Asthma—Epirubicin—pancreatic cancer	0.000325	0.000943	CcSEcCtD
Arformoterol—Influenza—Epirubicin—pancreatic cancer	0.000325	0.000943	CcSEcCtD
Arformoterol—Back pain—Docetaxel—pancreatic cancer	0.000325	0.000942	CcSEcCtD
Arformoterol—Pain—Fluorouracil—pancreatic cancer	0.000325	0.000942	CcSEcCtD
Arformoterol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000325	0.000941	CcSEcCtD
Arformoterol—Dehydration—Doxorubicin—pancreatic cancer	0.000324	0.000939	CcSEcCtD
Arformoterol—Muscle spasms—Docetaxel—pancreatic cancer	0.000323	0.000937	CcSEcCtD
Arformoterol—Dry skin—Doxorubicin—pancreatic cancer	0.000319	0.000926	CcSEcCtD
Arformoterol—Dizziness—Sunitinib—pancreatic cancer	0.000319	0.000923	CcSEcCtD
Arformoterol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000319	0.000923	CcSEcCtD
Arformoterol—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000317	0.000919	CcSEcCtD
Arformoterol—Angina pectoris—Epirubicin—pancreatic cancer	0.000317	0.000919	CcSEcCtD
Arformoterol—Abdominal pain—Irinotecan—pancreatic cancer	0.000314	0.000909	CcSEcCtD
Arformoterol—Body temperature increased—Irinotecan—pancreatic cancer	0.000314	0.000909	CcSEcCtD
Arformoterol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000313	0.000908	CcSEcCtD
Arformoterol—Bronchitis—Epirubicin—pancreatic cancer	0.000313	0.000907	CcSEcCtD
Arformoterol—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000312	0.000903	CcSEcCtD
Arformoterol—Gastritis—Doxorubicin—pancreatic cancer	0.000308	0.000894	CcSEcCtD
Arformoterol—Vomiting—Sunitinib—pancreatic cancer	0.000306	0.000888	CcSEcCtD
Arformoterol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000306	0.000886	CcSEcCtD
Arformoterol—Rash—Sunitinib—pancreatic cancer	0.000304	0.000881	CcSEcCtD
Arformoterol—Dermatitis—Sunitinib—pancreatic cancer	0.000304	0.00088	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000302	0.000877	CcSEcCtD
Arformoterol—Urticaria—Fluorouracil—pancreatic cancer	0.000302	0.000875	CcSEcCtD
Arformoterol—Headache—Sunitinib—pancreatic cancer	0.000302	0.000875	CcSEcCtD
Arformoterol—Influenza—Doxorubicin—pancreatic cancer	0.000301	0.000873	CcSEcCtD
Arformoterol—Asthma—Doxorubicin—pancreatic cancer	0.000301	0.000873	CcSEcCtD
Arformoterol—Body temperature increased—Fluorouracil—pancreatic cancer	0.000301	0.000871	CcSEcCtD
Arformoterol—Palpitations—Docetaxel—pancreatic cancer	0.000297	0.000861	CcSEcCtD
Arformoterol—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000294	0.000851	CcSEcCtD
Arformoterol—Cough—Docetaxel—pancreatic cancer	0.000293	0.00085	CcSEcCtD
Arformoterol—Angina pectoris—Doxorubicin—pancreatic cancer	0.000293	0.00085	CcSEcCtD
Arformoterol—Hypersensitivity—Irinotecan—pancreatic cancer	0.000292	0.000848	CcSEcCtD
Arformoterol—Hypertension—Docetaxel—pancreatic cancer	0.00029	0.000841	CcSEcCtD
Arformoterol—Bronchitis—Doxorubicin—pancreatic cancer	0.00029	0.000839	CcSEcCtD
Arformoterol—Arthralgia—Docetaxel—pancreatic cancer	0.000286	0.00083	CcSEcCtD
Arformoterol—Chest pain—Docetaxel—pancreatic cancer	0.000286	0.00083	CcSEcCtD
Arformoterol—Myalgia—Docetaxel—pancreatic cancer	0.000286	0.00083	CcSEcCtD
Arformoterol—Nausea—Sunitinib—pancreatic cancer	0.000286	0.00083	CcSEcCtD
Arformoterol—Asthenia—Irinotecan—pancreatic cancer	0.000285	0.000825	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000284	0.000824	CcSEcCtD
Arformoterol—Urinary tract infection—Epirubicin—pancreatic cancer	0.000282	0.000817	CcSEcCtD
Arformoterol—Conjunctivitis—Epirubicin—pancreatic cancer	0.000282	0.000817	CcSEcCtD
Arformoterol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00028	0.000812	CcSEcCtD
Arformoterol—Dry mouth—Docetaxel—pancreatic cancer	0.00028	0.000811	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.00028	0.000811	CcSEcCtD
Arformoterol—Asthenia—Gemcitabine—pancreatic cancer	0.000277	0.000804	CcSEcCtD
Arformoterol—Haematuria—Epirubicin—pancreatic cancer	0.000277	0.000802	CcSEcCtD
Arformoterol—Oedema—Docetaxel—pancreatic cancer	0.000274	0.000795	CcSEcCtD
Arformoterol—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000274	0.000795	CcSEcCtD
Arformoterol—Pruritus—Gemcitabine—pancreatic cancer	0.000274	0.000793	CcSEcCtD
Arformoterol—Infection—Docetaxel—pancreatic cancer	0.000273	0.00079	CcSEcCtD
Arformoterol—Sinusitis—Epirubicin—pancreatic cancer	0.000272	0.000789	CcSEcCtD
Arformoterol—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000272	0.000787	CcSEcCtD
Arformoterol—Diarrhoea—Irinotecan—pancreatic cancer	0.000272	0.000787	CcSEcCtD
Arformoterol—Nervous system disorder—Docetaxel—pancreatic cancer	0.000269	0.00078	CcSEcCtD
Arformoterol—Pruritus—Fluorouracil—pancreatic cancer	0.000269	0.000779	CcSEcCtD
Arformoterol—Tachycardia—Docetaxel—pancreatic cancer	0.000268	0.000776	CcSEcCtD
Arformoterol—Skin disorder—Docetaxel—pancreatic cancer	0.000267	0.000772	CcSEcCtD
Arformoterol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000265	0.000767	CcSEcCtD
Arformoterol—Dizziness—Irinotecan—pancreatic cancer	0.000262	0.000761	CcSEcCtD
Arformoterol—Rhinitis—Epirubicin—pancreatic cancer	0.000261	0.000757	CcSEcCtD
Arformoterol—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000261	0.000756	CcSEcCtD
Arformoterol—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000261	0.000756	CcSEcCtD
Arformoterol—Diarrhoea—Fluorouracil—pancreatic cancer	0.00026	0.000754	CcSEcCtD
Arformoterol—Pharyngitis—Epirubicin—pancreatic cancer	0.000259	0.000749	CcSEcCtD
Arformoterol—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000257	0.000746	CcSEcCtD
Arformoterol—Oedema peripheral—Epirubicin—pancreatic cancer	0.000257	0.000744	CcSEcCtD
Arformoterol—Hypotension—Docetaxel—pancreatic cancer	0.000256	0.000743	CcSEcCtD
Arformoterol—Haematuria—Doxorubicin—pancreatic cancer	0.000256	0.000742	CcSEcCtD
Arformoterol—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000256	0.000742	CcSEcCtD
Arformoterol—Urethral disorder—Epirubicin—pancreatic cancer	0.000255	0.00074	CcSEcCtD
Arformoterol—Vomiting—Irinotecan—pancreatic cancer	0.000252	0.000731	CcSEcCtD
Arformoterol—Sinusitis—Doxorubicin—pancreatic cancer	0.000252	0.00073	CcSEcCtD
Arformoterol—Dizziness—Fluorouracil—pancreatic cancer	0.000251	0.000729	CcSEcCtD
Arformoterol—Visual impairment—Epirubicin—pancreatic cancer	0.000251	0.000728	CcSEcCtD
Arformoterol—Rash—Irinotecan—pancreatic cancer	0.00025	0.000725	CcSEcCtD
Arformoterol—Dermatitis—Irinotecan—pancreatic cancer	0.00025	0.000725	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00025	0.000724	CcSEcCtD
Arformoterol—Headache—Irinotecan—pancreatic cancer	0.000249	0.000721	CcSEcCtD
Arformoterol—Insomnia—Docetaxel—pancreatic cancer	0.000248	0.000719	CcSEcCtD
Arformoterol—Vomiting—Gemcitabine—pancreatic cancer	0.000246	0.000712	CcSEcCtD
Arformoterol—Dyspnoea—Docetaxel—pancreatic cancer	0.000245	0.000709	CcSEcCtD
Arformoterol—Somnolence—Docetaxel—pancreatic cancer	0.000244	0.000707	CcSEcCtD
Arformoterol—Rash—Gemcitabine—pancreatic cancer	0.000244	0.000707	CcSEcCtD
Arformoterol—Dermatitis—Gemcitabine—pancreatic cancer	0.000244	0.000706	CcSEcCtD
Arformoterol—Headache—Gemcitabine—pancreatic cancer	0.000242	0.000702	CcSEcCtD
Arformoterol—Cardiac disorder—Epirubicin—pancreatic cancer	0.000242	0.000701	CcSEcCtD
Arformoterol—Vomiting—Fluorouracil—pancreatic cancer	0.000242	0.000701	CcSEcCtD
Arformoterol—Rhinitis—Doxorubicin—pancreatic cancer	0.000242	0.0007	CcSEcCtD
Arformoterol—Dyspepsia—Docetaxel—pancreatic cancer	0.000242	0.0007	CcSEcCtD
Arformoterol—Rash—Fluorouracil—pancreatic cancer	0.00024	0.000695	CcSEcCtD
Arformoterol—Dermatitis—Fluorouracil—pancreatic cancer	0.000239	0.000694	CcSEcCtD
Arformoterol—Pharyngitis—Doxorubicin—pancreatic cancer	0.000239	0.000693	CcSEcCtD
Arformoterol—Headache—Fluorouracil—pancreatic cancer	0.000238	0.00069	CcSEcCtD
Arformoterol—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000238	0.00069	CcSEcCtD
Arformoterol—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000237	0.000688	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000237	0.000687	CcSEcCtD
Arformoterol—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000237	0.000686	CcSEcCtD
Arformoterol—Fatigue—Docetaxel—pancreatic cancer	0.000237	0.000686	CcSEcCtD
Arformoterol—Urethral disorder—Doxorubicin—pancreatic cancer	0.000236	0.000685	CcSEcCtD
Arformoterol—Nausea—Irinotecan—pancreatic cancer	0.000236	0.000683	CcSEcCtD
Arformoterol—Immune system disorder—Epirubicin—pancreatic cancer	0.000235	0.000682	CcSEcCtD
Arformoterol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000235	0.00068	CcSEcCtD
Arformoterol—Pain—Docetaxel—pancreatic cancer	0.000235	0.00068	CcSEcCtD
Arformoterol—Constipation—Docetaxel—pancreatic cancer	0.000235	0.00068	CcSEcCtD
Arformoterol—Arrhythmia—Epirubicin—pancreatic cancer	0.000233	0.000674	CcSEcCtD
Arformoterol—Visual impairment—Doxorubicin—pancreatic cancer	0.000232	0.000673	CcSEcCtD
Arformoterol—Nausea—Gemcitabine—pancreatic cancer	0.00023	0.000666	CcSEcCtD
Arformoterol—Mental disorder—Epirubicin—pancreatic cancer	0.000228	0.000661	CcSEcCtD
Arformoterol—Malnutrition—Epirubicin—pancreatic cancer	0.000227	0.000657	CcSEcCtD
Arformoterol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000226	0.000655	CcSEcCtD
Arformoterol—Nausea—Fluorouracil—pancreatic cancer	0.000226	0.000654	CcSEcCtD
Arformoterol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000224	0.00065	CcSEcCtD
Arformoterol—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000224	0.000648	CcSEcCtD
Arformoterol—Tension—Epirubicin—pancreatic cancer	0.000223	0.000645	CcSEcCtD
Arformoterol—Dysgeusia—Epirubicin—pancreatic cancer	0.000222	0.000644	CcSEcCtD
Arformoterol—Nervousness—Epirubicin—pancreatic cancer	0.00022	0.000638	CcSEcCtD
Arformoterol—Back pain—Epirubicin—pancreatic cancer	0.000219	0.000636	CcSEcCtD
Arformoterol—Muscle spasms—Epirubicin—pancreatic cancer	0.000218	0.000632	CcSEcCtD
Arformoterol—Immune system disorder—Doxorubicin—pancreatic cancer	0.000218	0.000631	CcSEcCtD
Arformoterol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000217	0.00063	CcSEcCtD
Arformoterol—Body temperature increased—Docetaxel—pancreatic cancer	0.000217	0.000629	CcSEcCtD
Arformoterol—Abdominal pain—Docetaxel—pancreatic cancer	0.000217	0.000629	CcSEcCtD
Arformoterol—Arrhythmia—Doxorubicin—pancreatic cancer	0.000215	0.000624	CcSEcCtD
Arformoterol—Mental disorder—Doxorubicin—pancreatic cancer	0.000211	0.000612	CcSEcCtD
Arformoterol—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00021	0.00061	CcSEcCtD
Arformoterol—Malnutrition—Doxorubicin—pancreatic cancer	0.00021	0.000608	CcSEcCtD
Arformoterol—Agitation—Epirubicin—pancreatic cancer	0.000208	0.000604	CcSEcCtD
Arformoterol—Tension—Doxorubicin—pancreatic cancer	0.000206	0.000597	CcSEcCtD
Arformoterol—Dysgeusia—Doxorubicin—pancreatic cancer	0.000205	0.000595	CcSEcCtD
Arformoterol—Malaise—Epirubicin—pancreatic cancer	0.000204	0.000593	CcSEcCtD
Arformoterol—Nervousness—Doxorubicin—pancreatic cancer	0.000204	0.000591	CcSEcCtD
Arformoterol—Back pain—Doxorubicin—pancreatic cancer	0.000203	0.000588	CcSEcCtD
Arformoterol—Hypersensitivity—Docetaxel—pancreatic cancer	0.000202	0.000586	CcSEcCtD
Arformoterol—Muscle spasms—Doxorubicin—pancreatic cancer	0.000202	0.000585	CcSEcCtD
Arformoterol—Palpitations—Epirubicin—pancreatic cancer	0.0002	0.000581	CcSEcCtD
Arformoterol—Cough—Epirubicin—pancreatic cancer	0.000198	0.000573	CcSEcCtD
Arformoterol—Asthenia—Docetaxel—pancreatic cancer	0.000197	0.000571	CcSEcCtD
Arformoterol—Hypertension—Epirubicin—pancreatic cancer	0.000196	0.000567	CcSEcCtD
Arformoterol—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000195	0.000564	CcSEcCtD
Arformoterol—Pruritus—Docetaxel—pancreatic cancer	0.000194	0.000563	CcSEcCtD
Arformoterol—Chest pain—Epirubicin—pancreatic cancer	0.000193	0.00056	CcSEcCtD
Arformoterol—Myalgia—Epirubicin—pancreatic cancer	0.000193	0.00056	CcSEcCtD
Arformoterol—Arthralgia—Epirubicin—pancreatic cancer	0.000193	0.00056	CcSEcCtD
Arformoterol—Agitation—Doxorubicin—pancreatic cancer	0.000193	0.000559	CcSEcCtD
Arformoterol—Anxiety—Epirubicin—pancreatic cancer	0.000192	0.000558	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000192	0.000556	CcSEcCtD
Arformoterol—Discomfort—Epirubicin—pancreatic cancer	0.000191	0.000553	CcSEcCtD
Arformoterol—Malaise—Doxorubicin—pancreatic cancer	0.000189	0.000548	CcSEcCtD
Arformoterol—Dry mouth—Epirubicin—pancreatic cancer	0.000189	0.000547	CcSEcCtD
Arformoterol—Diarrhoea—Docetaxel—pancreatic cancer	0.000188	0.000544	CcSEcCtD
Arformoterol—Palpitations—Doxorubicin—pancreatic cancer	0.000185	0.000537	CcSEcCtD
Arformoterol—Oedema—Epirubicin—pancreatic cancer	0.000185	0.000536	CcSEcCtD
Arformoterol—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000185	0.000536	CcSEcCtD
Arformoterol—Infection—Epirubicin—pancreatic cancer	0.000184	0.000533	CcSEcCtD
Arformoterol—Cough—Doxorubicin—pancreatic cancer	0.000183	0.000531	CcSEcCtD
Arformoterol—Nervous system disorder—Epirubicin—pancreatic cancer	0.000181	0.000526	CcSEcCtD
Arformoterol—Dizziness—Docetaxel—pancreatic cancer	0.000181	0.000526	CcSEcCtD
Arformoterol—Hypertension—Doxorubicin—pancreatic cancer	0.000181	0.000525	CcSEcCtD
Arformoterol—Tachycardia—Epirubicin—pancreatic cancer	0.000181	0.000523	CcSEcCtD
Arformoterol—Skin disorder—Epirubicin—pancreatic cancer	0.00018	0.000521	CcSEcCtD
Arformoterol—Arthralgia—Doxorubicin—pancreatic cancer	0.000179	0.000518	CcSEcCtD
Arformoterol—Chest pain—Doxorubicin—pancreatic cancer	0.000179	0.000518	CcSEcCtD
Arformoterol—Myalgia—Doxorubicin—pancreatic cancer	0.000179	0.000518	CcSEcCtD
Arformoterol—Anxiety—Doxorubicin—pancreatic cancer	0.000178	0.000516	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000177	0.000514	CcSEcCtD
Arformoterol—Discomfort—Doxorubicin—pancreatic cancer	0.000176	0.000512	CcSEcCtD
Arformoterol—Dry mouth—Doxorubicin—pancreatic cancer	0.000175	0.000506	CcSEcCtD
Arformoterol—Vomiting—Docetaxel—pancreatic cancer	0.000174	0.000506	CcSEcCtD
Arformoterol—Rash—Docetaxel—pancreatic cancer	0.000173	0.000501	CcSEcCtD
Arformoterol—Hypotension—Epirubicin—pancreatic cancer	0.000173	0.000501	CcSEcCtD
Arformoterol—Dermatitis—Docetaxel—pancreatic cancer	0.000173	0.000501	CcSEcCtD
Arformoterol—Headache—Docetaxel—pancreatic cancer	0.000172	0.000498	CcSEcCtD
Arformoterol—Oedema—Doxorubicin—pancreatic cancer	0.000171	0.000496	CcSEcCtD
Arformoterol—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000171	0.000496	CcSEcCtD
Arformoterol—Infection—Doxorubicin—pancreatic cancer	0.00017	0.000493	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000169	0.000489	CcSEcCtD
Arformoterol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000168	0.000487	CcSEcCtD
Arformoterol—Insomnia—Epirubicin—pancreatic cancer	0.000167	0.000485	CcSEcCtD
Arformoterol—Tachycardia—Doxorubicin—pancreatic cancer	0.000167	0.000484	CcSEcCtD
Arformoterol—Skin disorder—Doxorubicin—pancreatic cancer	0.000166	0.000482	CcSEcCtD
Arformoterol—Dyspnoea—Epirubicin—pancreatic cancer	0.000165	0.000478	CcSEcCtD
Arformoterol—Somnolence—Epirubicin—pancreatic cancer	0.000165	0.000477	CcSEcCtD
Arformoterol—Nausea—Docetaxel—pancreatic cancer	0.000163	0.000472	CcSEcCtD
Arformoterol—Dyspepsia—Epirubicin—pancreatic cancer	0.000163	0.000472	CcSEcCtD
Arformoterol—Hypotension—Doxorubicin—pancreatic cancer	0.00016	0.000464	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00016	0.000463	CcSEcCtD
Arformoterol—Fatigue—Epirubicin—pancreatic cancer	0.00016	0.000462	CcSEcCtD
Arformoterol—Constipation—Epirubicin—pancreatic cancer	0.000158	0.000459	CcSEcCtD
Arformoterol—Pain—Epirubicin—pancreatic cancer	0.000158	0.000459	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000156	0.000452	CcSEcCtD
Arformoterol—Insomnia—Doxorubicin—pancreatic cancer	0.000155	0.000449	CcSEcCtD
Arformoterol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000153	0.000442	CcSEcCtD
Arformoterol—Feeling abnormal—Epirubicin—pancreatic cancer	0.000153	0.000442	CcSEcCtD
Arformoterol—Somnolence—Doxorubicin—pancreatic cancer	0.000152	0.000441	CcSEcCtD
Arformoterol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000151	0.000439	CcSEcCtD
Arformoterol—Dyspepsia—Doxorubicin—pancreatic cancer	0.000151	0.000437	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000148	0.000428	CcSEcCtD
Arformoterol—Fatigue—Doxorubicin—pancreatic cancer	0.000148	0.000428	CcSEcCtD
Arformoterol—Urticaria—Epirubicin—pancreatic cancer	0.000147	0.000426	CcSEcCtD
Arformoterol—Pain—Doxorubicin—pancreatic cancer	0.000146	0.000424	CcSEcCtD
Arformoterol—Constipation—Doxorubicin—pancreatic cancer	0.000146	0.000424	CcSEcCtD
Arformoterol—Body temperature increased—Epirubicin—pancreatic cancer	0.000146	0.000424	CcSEcCtD
Arformoterol—Abdominal pain—Epirubicin—pancreatic cancer	0.000146	0.000424	CcSEcCtD
Arformoterol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000141	0.000409	CcSEcCtD
Arformoterol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00014	0.000406	CcSEcCtD
Arformoterol—Hypersensitivity—Epirubicin—pancreatic cancer	0.000136	0.000395	CcSEcCtD
Arformoterol—Urticaria—Doxorubicin—pancreatic cancer	0.000136	0.000394	CcSEcCtD
Arformoterol—Body temperature increased—Doxorubicin—pancreatic cancer	0.000135	0.000392	CcSEcCtD
Arformoterol—Abdominal pain—Doxorubicin—pancreatic cancer	0.000135	0.000392	CcSEcCtD
Arformoterol—Asthenia—Epirubicin—pancreatic cancer	0.000133	0.000385	CcSEcCtD
Arformoterol—Pruritus—Epirubicin—pancreatic cancer	0.000131	0.000379	CcSEcCtD
Arformoterol—Diarrhoea—Epirubicin—pancreatic cancer	0.000127	0.000367	CcSEcCtD
Arformoterol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000126	0.000366	CcSEcCtD
Arformoterol—Asthenia—Doxorubicin—pancreatic cancer	0.000123	0.000356	CcSEcCtD
Arformoterol—Dizziness—Epirubicin—pancreatic cancer	0.000122	0.000355	CcSEcCtD
Arformoterol—Pruritus—Doxorubicin—pancreatic cancer	0.000121	0.000351	CcSEcCtD
Arformoterol—Vomiting—Epirubicin—pancreatic cancer	0.000118	0.000341	CcSEcCtD
Arformoterol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000117	0.00034	CcSEcCtD
Arformoterol—Rash—Epirubicin—pancreatic cancer	0.000117	0.000338	CcSEcCtD
Arformoterol—Dermatitis—Epirubicin—pancreatic cancer	0.000117	0.000338	CcSEcCtD
Arformoterol—Headache—Epirubicin—pancreatic cancer	0.000116	0.000336	CcSEcCtD
Arformoterol—Dizziness—Doxorubicin—pancreatic cancer	0.000113	0.000328	CcSEcCtD
Arformoterol—Nausea—Epirubicin—pancreatic cancer	0.00011	0.000319	CcSEcCtD
Arformoterol—Vomiting—Doxorubicin—pancreatic cancer	0.000109	0.000316	CcSEcCtD
Arformoterol—Rash—Doxorubicin—pancreatic cancer	0.000108	0.000313	CcSEcCtD
Arformoterol—Dermatitis—Doxorubicin—pancreatic cancer	0.000108	0.000313	CcSEcCtD
Arformoterol—Headache—Doxorubicin—pancreatic cancer	0.000107	0.000311	CcSEcCtD
Arformoterol—Nausea—Doxorubicin—pancreatic cancer	0.000102	0.000295	CcSEcCtD
Arformoterol—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	2.73e-05	0.00112	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	2.73e-05	0.00112	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—SST—pancreatic cancer	2.72e-05	0.00112	CbGpPWpGaD
Arformoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	2.71e-05	0.00111	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	2.67e-05	0.0011	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	2.62e-05	0.00108	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	2.62e-05	0.00108	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	2.61e-05	0.00107	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	2.57e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	2.57e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	2.57e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	2.55e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	2.55e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	2.55e-05	0.00105	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	2.51e-05	0.00103	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	2.5e-05	0.00102	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	2.5e-05	0.00102	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	2.48e-05	0.00102	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	2.46e-05	0.00101	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	2.43e-05	0.000996	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	2.4e-05	0.000986	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	2.4e-05	0.000985	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	2.37e-05	0.000972	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	2.35e-05	0.000964	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	2.32e-05	0.000951	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	2.27e-05	0.000934	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	2.27e-05	0.000934	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	2.23e-05	0.000913	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	2.23e-05	0.000913	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GLP1R—pancreatic cancer	2.21e-05	0.000907	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PRSS1—pancreatic cancer	2.2e-05	0.000905	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—DPYD—pancreatic cancer	2.17e-05	0.000892	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	2.17e-05	0.000891	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	2.12e-05	0.000871	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	2.11e-05	0.000868	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	2.11e-05	0.000868	CbGpPWpGaD
Arformoterol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	2.11e-05	0.000868	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	2.08e-05	0.000854	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	2.07e-05	0.000849	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	2.07e-05	0.000849	CbGpPWpGaD
Arformoterol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	2.07e-05	0.000849	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—SLC2A2—pancreatic cancer	2.06e-05	0.000847	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	2.04e-05	0.000835	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PRSS1—pancreatic cancer	2.03e-05	0.000833	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	2.02e-05	0.000828	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PRSS1—pancreatic cancer	2.01e-05	0.000825	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	1.99e-05	0.000816	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	1.97e-05	0.00081	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	1.94e-05	0.000798	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—ARG2—pancreatic cancer	1.91e-05	0.000785	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	1.9e-05	0.000779	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	1.88e-05	0.000774	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	1.87e-05	0.000769	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	1.86e-05	0.000762	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	1.84e-05	0.000757	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	1.83e-05	0.000752	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	1.8e-05	0.000738	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	1.8e-05	0.000738	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	1.76e-05	0.000722	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	1.76e-05	0.000722	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.76e-05	0.000722	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.74e-05	0.000716	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.67e-05	0.000686	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SST—pancreatic cancer	1.64e-05	0.000675	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.62e-05	0.000666	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	1.61e-05	0.000661	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SST—pancreatic cancer	1.61e-05	0.00066	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	1.6e-05	0.000658	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—CD44—pancreatic cancer	1.6e-05	0.000656	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.59e-05	0.000651	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	1.57e-05	0.000646	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	1.57e-05	0.000644	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.54e-05	0.000631	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—GCG—pancreatic cancer	1.53e-05	0.000629	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.52e-05	0.000625	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	1.52e-05	0.000623	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	1.48e-05	0.000609	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.47e-05	0.000605	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	1.47e-05	0.000602	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.44e-05	0.000591	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—STK11—pancreatic cancer	1.44e-05	0.000591	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	1.43e-05	0.000589	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.43e-05	0.000585	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	1.4e-05	0.000574	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.39e-05	0.000573	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.38e-05	0.000566	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	1.38e-05	0.000566	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	1.37e-05	0.000561	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	1.35e-05	0.000553	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.35e-05	0.000553	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.33e-05	0.000544	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.29e-05	0.000532	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.27e-05	0.00052	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.26e-05	0.000516	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.26e-05	0.000516	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.24e-05	0.000511	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.24e-05	0.00051	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.24e-05	0.000509	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—TYMS—pancreatic cancer	1.24e-05	0.000508	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.23e-05	0.000504	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.22e-05	0.0005	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.22e-05	0.000499	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.21e-05	0.000496	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	1.21e-05	0.000495	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.2e-05	0.000493	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.19e-05	0.00049	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	1.18e-05	0.000485	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	1.18e-05	0.000484	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.17e-05	0.00048	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.16e-05	0.000475	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	1.15e-05	0.000473	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.15e-05	0.000471	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.13e-05	0.000466	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.13e-05	0.000463	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.1e-05	0.000453	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.1e-05	0.00045	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.09e-05	0.000449	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	1.08e-05	0.000445	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	1.06e-05	0.000436	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	1.03e-05	0.000424	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	1.01e-05	0.000415	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—APOE—pancreatic cancer	1.01e-05	0.000413	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.98e-06	0.000409	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	9.88e-06	0.000405	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	9.85e-06	0.000404	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—CD44—pancreatic cancer	9.74e-06	0.0004	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	9.66e-06	0.000397	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	9.64e-06	0.000396	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	9.64e-06	0.000396	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.54e-06	0.000391	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.45e-06	0.000388	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	9.44e-06	0.000388	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	9.43e-06	0.000387	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—GCG—pancreatic cancer	9.34e-06	0.000383	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	9.24e-06	0.000379	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	9.09e-06	0.000373	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	8.98e-06	0.000369	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—CD44—pancreatic cancer	8.96e-06	0.000368	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	8.9e-06	0.000365	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—CD44—pancreatic cancer	8.88e-06	0.000365	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	8.79e-06	0.000361	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—STK11—pancreatic cancer	8.78e-06	0.00036	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PPARG—pancreatic cancer	8.77e-06	0.00036	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	8.7e-06	0.000357	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	8.7e-06	0.000357	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	8.7e-06	0.000357	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.69e-06	0.000357	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.61e-06	0.000354	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	8.6e-06	0.000353	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—GCG—pancreatic cancer	8.59e-06	0.000353	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—GCG—pancreatic cancer	8.51e-06	0.000349	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	8.51e-06	0.000349	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	8.51e-06	0.000349	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	8.41e-06	0.000345	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.24e-06	0.000338	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—STK11—pancreatic cancer	8.07e-06	0.000331	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—STK11—pancreatic cancer	8e-06	0.000329	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	7.99e-06	0.000328	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	7.93e-06	0.000325	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	7.75e-06	0.000318	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	7.65e-06	0.000314	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.58e-06	0.000311	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—TYMS—pancreatic cancer	7.55e-06	0.00031	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.51e-06	0.000308	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	7.49e-06	0.000307	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	7.48e-06	0.000307	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.41e-06	0.000304	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	7.33e-06	0.000301	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	6.97e-06	0.000286	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—TYMS—pancreatic cancer	6.94e-06	0.000285	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PTGS2—pancreatic cancer	6.9e-06	0.000283	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—TYMS—pancreatic cancer	6.88e-06	0.000283	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	6.88e-06	0.000282	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	6.73e-06	0.000276	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	6.67e-06	0.000274	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	6.52e-06	0.000268	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	6.41e-06	0.000263	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	6.37e-06	0.000261	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	6.27e-06	0.000257	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	6.23e-06	0.000256	CbGpPWpGaD
Arformoterol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	6.19e-06	0.000254	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—APOE—pancreatic cancer	6.14e-06	0.000252	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	6.13e-06	0.000252	CbGpPWpGaD
Arformoterol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	6.05e-06	0.000249	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PTEN—pancreatic cancer	6.02e-06	0.000247	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	6e-06	0.000246	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	5.97e-06	0.000245	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	5.91e-06	0.000243	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	5.84e-06	0.00024	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.81e-06	0.000239	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	5.79e-06	0.000238	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	5.78e-06	0.000237	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	5.76e-06	0.000236	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	5.67e-06	0.000233	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—APOE—pancreatic cancer	5.65e-06	0.000232	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	5.64e-06	0.000231	CbGpPWpGaD
Arformoterol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	5.62e-06	0.000231	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—APOE—pancreatic cancer	5.6e-06	0.00023	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	5.54e-06	0.000228	CbGpPWpGaD
Arformoterol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	5.5e-06	0.000226	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PPARG—pancreatic cancer	5.35e-06	0.00022	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	5.34e-06	0.000219	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.3e-06	0.000218	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	5.23e-06	0.000215	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	5.2e-06	0.000214	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	5.15e-06	0.000212	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	5.14e-06	0.000211	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	5.1e-06	0.000209	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	5.09e-06	0.000209	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	5.05e-06	0.000207	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	5.04e-06	0.000207	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	5.03e-06	0.000206	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PPARG—pancreatic cancer	4.92e-06	0.000202	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PPARG—pancreatic cancer	4.88e-06	0.0002	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	4.87e-06	0.0002	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	4.79e-06	0.000197	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	4.78e-06	0.000196	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	4.68e-06	0.000192	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	4.68e-06	0.000192	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	4.67e-06	0.000192	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	4.58e-06	0.000188	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	4.48e-06	0.000184	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	4.44e-06	0.000182	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	4.42e-06	0.000182	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	4.33e-06	0.000178	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	4.25e-06	0.000174	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	4.25e-06	0.000174	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PTGS2—pancreatic cancer	4.21e-06	0.000173	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	4.06e-06	0.000167	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	3.98e-06	0.000163	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	3.93e-06	0.000161	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.91e-06	0.00016	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.87e-06	0.000159	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.87e-06	0.000159	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	3.85e-06	0.000158	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.84e-06	0.000157	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	3.76e-06	0.000154	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	3.68e-06	0.000151	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PTEN—pancreatic cancer	3.67e-06	0.000151	CbGpPWpGaD
Arformoterol—CYP2A6—Metabolism—AKT1—pancreatic cancer	3.47e-06	0.000142	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.38e-06	0.000139	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PTEN—pancreatic cancer	3.35e-06	0.000137	CbGpPWpGaD
Arformoterol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	3.32e-06	0.000136	CbGpPWpGaD
Arformoterol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	3.25e-06	0.000133	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.59e-06	0.000106	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.38e-06	9.77e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.36e-06	9.69e-05	CbGpPWpGaD
Arformoterol—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.11e-06	8.68e-05	CbGpPWpGaD
Arformoterol—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.95e-06	7.98e-05	CbGpPWpGaD
Arformoterol—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.93e-06	7.92e-05	CbGpPWpGaD
